NUDCD1 Antikörper (Middle Region)
Kurzübersicht für NUDCD1 Antikörper (Middle Region) (ABIN953777)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 193-223, Middle Region
-
Spezifität
- This antibody recognizes Human NUDCD1 / CML66 (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 193-223 amino acids from the Central region of Human NUDCD1
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- NUDCD1 (NudC Domain Containing 1 (NUDCD1))
-
Andere Bezeichnung
- NUDCD1 / CML66
-
Hintergrund
- NUDCD1 (CML66) contains 1 CS domain. It may play an oncogenic role in ways of favoring tumor cells proliferation, invasion and metastasis-associated with multiple pathways. NUDCD1 is expressed in leukemias and a variety of solid tumor cell lines. Northern blot analysis showed expression in normal tissues restricted to testis and heart, and no expression was found in hematopoietic tissues.Synonyms: Chronic myelogenous leukemia tumor antigen 66, NudC domain-containing protein 1, Tumor antigen CML66
-
Molekulargewicht
- 66756 Da
-
Gen-ID
- 84955
-
NCBI Accession
- NP_001121683
Target
-